Long-term foot outcomes following differential abatement of inflammation and osteoclastogenesis for active Charcot neuroarthropathy in diabetes mellitus
<h4>Aims</h4> Inflammatory osteolysis is sine-qua-non of active Charcot neuroarthropathy (CN) causing decreased foot bone mineral density (BMD) and fractures. We aimed to explore the effect of anti-inflammatory or anti-resorptive agents for effect on foot bone mineral content (BMC) and c...
Saved in:
Main Authors: | Liza Das, Ashu Rastogi, Edward B. Jude, Mahesh Prakash, Pinaki Dutta, Anil Bhansali |
---|---|
Format: | article |
Language: | EN |
Published: |
Public Library of Science (PLoS)
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/5d6674ba331949af8f28faaffa493d0b |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Long-term foot outcomes following differential abatement of inflammation and osteoclastogenesis for active Charcot neuroarthropathy in diabetes mellitus.
by: Liza Das, et al.
Published: (2021) -
Surgical treatment of Charcot foot with purulent infection
by: Valeriy Afanas'evich Mitish, et al.
Published: (2009) -
Criteria of immobilization duration of the affected foot in diabetic Charcot neuro-osteoarthropathy
by: Anastasia Gennad'evna Demina, et al.
Published: (2014) -
A prospective randomized controlled trial of bone metabolism in patients with charcot foot
by: Ekaterina L. Zaitseva, et al.
Published: (2020) -
Short-term outcomes of treatment of active stage of Charcot foot in outpatient setting
by: Anastasia G. Demina, et al.
Published: (2020)